Latest News about CASI
Recent news which mentions CASI
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
August 09, 2020
From Benzinga
81 Biggest Movers From Yesterday
July 28, 2020
From Benzinga
64 Stocks Moving In Monday's Mid-Day Session
July 27, 2020
From Benzinga
31 Stocks Moving in Monday's Pre-Market Session
July 27, 2020
From Benzinga
68 Biggest Movers From Yesterday
July 23, 2020
From Benzinga
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
July 22, 2020
From Benzinga
70 Biggest Movers From Yesterday
May 21, 2020
From Benzinga
52 Stocks Moving In Wednesday's Mid-Day Session
May 20, 2020
From Benzinga
Tickers
CASI
From Motley Fool
Stocks That Hit 52-Week Lows On Thursday
March 12, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
March 12, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 11, 2020
From Benzinga
20 Healthcare Stocks Moving In Monday's Session
March 09, 2020
From Benzinga
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
March 05, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
March 04, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 28, 2020
From Benzinga
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
February 28, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 27, 2020
From Benzinga
The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
February 21, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
February 20, 2020
From Benzinga
The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study
February 20, 2020
From Benzinga
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
February 13, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 12, 2020
From Benzinga
The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology
February 11, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Monday
February 10, 2020
From Benzinga
The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data
February 05, 2020
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 04, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.